CorMedix Inc (CRMD) insider trading

Every open-market stock purchase and sale by CorMedix Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders bought $276K over the last 12 months (1 buy).
  • Insiders sold $2.6M over the last 12 months (8 sales).
  • Last insider buy: Myron Kaplan (Director), $276K, 11 months ago.

Last 12 months: insiders bought $276K (1 buy) and sold $2.6M (8 sales). Last close $8.36 on Jun 4, 2026.

Recent CRMD insider trades

DateInsiderTradeValue
Feb 4, 2026Joseph Todisco (CEO)Bought (not open market)—
Feb 4, 2026Kaufman Beth Zelnick (C-suite exec)Bought (not open market)—
Feb 4, 2026Elizabeth Hurlburt (COO)Bought (not open market)—
Jan 26, 2026Janet Dillione (Director)Bought (not open market)—
Jan 26, 2026Gregory Scott Duncan (Director)Bought (not open market)—
Jan 26, 2026Alan W Dunton (Director)Bought (not open market)—
Jan 26, 2026Robert A Stewart (Director)Bought (not open market)—
Jan 26, 2026Steven W Lefkowitz (Director)Bought (not open market)—
Jan 26, 2026Myron Kaplan (Director)Bought (not open market)—
Jan 23, 2026Joseph Todisco (CEO)Sold (not open market)$199K
Jan 23, 2026Elizabeth Hurlburt (COO)Sold (not open market)$78.4K
Jan 23, 2026Susan Blum (CFO)Sold (not open market)$71K
Jan 23, 2026Kaufman Beth Zelnick (C-suite exec)Sold (not open market)$64K
Jan 23, 2026Susan Blum (CFO)Bought (not open market)—
Jan 23, 2026Joseph Todisco (CEO)Bought (not open market)—
Jan 23, 2026Kaufman Beth Zelnick (C-suite exec)Bought (not open market)—
Jan 23, 2026Elizabeth Hurlburt (COO)Bought (not open market)—
Jan 21, 2026Janet Dillione (Director)Sold$68.8K
Jan 17, 2026Joseph Todisco (CEO)Sold (not open market)$154K
Jan 16, 2026Joseph Todisco (CEO)Bought (not open market)—
Jan 12, 2026Joseph Todisco (CEO)Sold (not open market)$125K
Jan 12, 2026Elizabeth Hurlburt (COO)Sold (not open market)$41.4K
Jan 12, 2026Steven W Lefkowitz (Director)Bought (not open market)—
Jan 8, 2026Michael David Seckler (C-suite exec)Bought (not open market)—
Jan 2, 2026Kaufman Beth Zelnick (C-suite exec)Sold (not open market)$138K

Who's trading CRMD

Get free alerts when an insider at CorMedix Inc files a new trade →